Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > News & Updates > Regulatory Updates > Alternative Medicines > Deficiency Letters from EEC meetings from 95 to 103

Deficiency Letters from EEC meetings from 95 to 103

Yasir Mahmood Alternative Medicines, Enlistment Evaluation Committee March 7, 2022March 9, 2022
Deficiency-letter-of-95-meeting-of-EECDownload
Deficiency-letter-of-96-meeting-of-EECDownload
Deficiency-letter-of-97-meeting-of-EECDownload
Deficiency-letter-of-98-meeting-of-EECDownload
Deficiency-letter-of-99-meeting-of-EECDownload
Deficiency-letter-of-100-meeting-of-EECDownload
Deficiency-letter-of-101-meeting-of-EECDownload
Deficiency-letter-of-102-meeting-of-EECDownload
Deficiency-letter-of-103-meeting-of-EECDownload

Share this:

  • Twitter
  • Facebook
  • ← Online Training of Licensing Module of PIRIMS software will be held by the MIS Division on 01 Mar,2022 2:00 PM on DRAP Facebook page
  • Corrigendum(Tender Notice No. F.1-1/2019-(B&A) (Audit) dated 16-02- 2022) →
  • Guidelines
    • Pharmaceuticals
    • Biologicals
    • Medical Devices
    • Alternative Medicines & Health Products
    • Pharmacy Services
    • Pharmacovigilance
    • Quality Assurance
  • Newsletters
  • Regulatory Procedures
  • Regulatory Fees
  • Application Forms
  • Public Consultations
    • Open Consultations
    • Closed Consultations
    • How to Submit Comments
  • Minutes of the Meetings
    • Registration Board
    • Central Licensing Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee
  • Drugs
  • Medical Devices
  • Alternative Medicines
  • Controlled Substances
  • Licensing and Inspections
  • Clinical Trials
  • Pharmacovigilance
  • Advertisements
  • General

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem